SCHEMBL7047102

SCHEMBL7047102

Cc1noc(C)c1CS(=O)(=O)C(CNC(=O)N1CCOCC1)C(=O)NCCCCCC(=O)c1nc2ccccc2o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.38
CES1 P23141 2/20 0.38
DAGLA Q9Y4D2 1/20 0.38
ALDH1A1 P00352 4/20 0.34
KMT2A Q03164 3/20 0.34
TSHR P16473 3/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
KDM4E B2RXH2 1/20 0.33
AR P10275 1/20 0.33
ITGB3 P05106 1/20 0.33
ITGA2B P08514 1/20 0.33
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6463188 0.88 DAGLA (0.48) FAAHCES1DAGLAALDH1A1KMT2A
SCHEMBL6467366 0.87 DAGLA (0.47) FAAHCES1DAGLAALDH1A1KMT2A
SCHEMBL6465127 0.85 DAGLA (0.42) FAAHCES1DAGLAKMT2ATSHR
SCHEMBL7043175 0.85 DAGLA (0.46) FAAHCES1DAGLAALDH1A1KMT2A
SCHEMBL6467383 0.84 FAAH (0.40) FAAHCES1DAGLAALDH1A1KMT2A
SCHEMBL6467703 0.84 FAAH (0.40) FAAHCES1DAGLAALDH1A1KMT2A
SCHEMBL7045895 0.83 FAAH (0.38) FAAHCES1DAGLAALDH1A1SMN1; SMN2
SCHEMBL6461887 0.83 DRD2 (0.41) FAAHCES1DAGLAALDH1A1KMT2A
SCHEMBL6062448 0.83 FAAH (0.38) FAAHCES1DAGLAALDH1A1KMT2A
SCHEMBL6462778 0.83 KDM4E (0.39) FAAHCES1DAGLAALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2003-12-18 US disclosed
US-6576630-B1 Alkanoyl substituted benzooxazoles or naphthooxazoles AXYS PHARMACEUTICALS, INC. 2003-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors SERPINB1, CTRL, CTSZ FAAH 479/4885CES1 272/4885DAGLA 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.